Pure Global

Bilirubin Direct - India CDSCO Medical Device Registration

Bilirubin Direct is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000144_ee25ceeb0768c6b0cd1501c2ab6dcc2c_fe4ff9c6094e02a5dd65269024d69488. This device is marketed under the brand name LDH โ€“ DGKC. The license holder is Randox Laboratories (India) Pvt.Ltd, and it is classified as Device Class Class B. The approving authority is Karnataka.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Bilirubin Direct
UID: MFG/IVD/2022/000144_ee25ceeb0768c6b0cd1501c2ab6dcc2c_fe4ff9c6094e02a5dd65269024d69488

Brand Name

LDH โ€“ DGKC

Device Class

Class B

Approving Authority

Karnataka

Product Information

The Bilirubin Direct (LDH โ€“ DGKC) System Pack is a device intended for the quantitative in vitro determination of Direct Bilirubin in serum and plasma. This product is suitable for automated use and on a variety of open non-dedicated chemistry instruments

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing